Søgning på udtrykket 'prep' giver 49 resultater
Dokumenter [3] Sider [3] Kalender [3] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [3]
Fællesregional retningslinje for udlevering af forebyggende medicin mod HIV (PrEP), udgivet af Danske Regioner.
Arrangereret af AIDS-fondet og CHIP
Henvendelse til Danske regioner
Sider [3]
Arbejdsgrupper og udvalg under Dansk Selskab for Infektionsmedicin organiseres med en kerne på typisk 4-8 personer (maks. 10) herunder en tovholder. Bestyrelsen kan oprette og lukke arbejdsgrupper/udvalg. Ved oprettelse af arbejdsgruppe sender bestyrelsen invitation til infektionsmedicinske centre i alle regioner. Alle DSI medlemmer, med undtagelse af firma-medlemmer, kan indgå i arbejdsgrupper. Arbejdsgruppens tovholder og sammensætning fremgår her på siden. Arbejdsgruppens tovholder vælges i grupp…
…e HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era Curr HIV/AIDS Rep. 2015; 12: 6?15. HIV - persistence on ART & cure research:. Margolis et al: Latency reversal and viral clearance to cure HIV-1. Science. 2016; 253: aaf6517. PREP og PEP:. Fonner et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations: AIDS 2016 Jul 31;30(12):1973-83. Rodger et al. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-…
…dling (Lene). 12:00-12:45 Resistens (Ann-Brit Eg Hansen). 12:45-13:30 Frokost. 13:30-14:15 Klinisk håndtering af HIV I (Ole og Lene). 14:15-14.30 Pause. 14:30-15:30 Klinisk håndtering af HIV 2 - cases (Alle). 15:30-15:45 Pause. 15:45-16:30 PrEP, Long acting antiretrovirals og STDs (Gitte Kronborg). . Torsdag den 13. oktober. 08:15-09:15 HIV og Komorbiditet/EACS Guidelines (Lene). 09:15-09:30 Pause. 09:30-10:15 Cocomo, danske data vedr HIV og co-morbiditet (Susanne Dam). 10:15-1…
Kalender [3]
21. marts, Fredericia
23. marts 2021, Online
19. marts 2015, Auditorium 1, Rigshospitalet
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?International Journal of Infectious Diseases
16.04.2024
epidemics, avian influenza, H5N1, highly pathogenic avian influenza, HPAI
Journal of Acquired Immune Deficiency Syndromes
7.04.2024
Background: . People living with mental illness (PLMI) experience disproportionately high incidence of and vulnerability to HIV. Pre-exposure prophylaxis (PrEP) is an effective and safe HIV prevention method, but data regarding prescription to PLMI are lacking. Psychiatrists may serve as important points of access for PrEP prescription for PLMI. Methods: . We conducted a vignette-based study of residents in psychiatry and family medicine (FM) to assess likelihood of prescribing PrEP and assumptions about …
AIDS
30.03.2024
Objective: . We assessed the association and concordance between self-reported oral preexposure prophylaxis (PrEP) intake in a diary app and intraerythrocytic drug metabolite concentrations. Design: . AMPrEP was a prospective demonstration study providing daily and event-driven PrEP to MSM in Amsterdam, the Netherlands (2015–2020). Methods: . Participants could record their PrEP intake in a diary app. Dried blood spots (DBS) were taken at 6, 12, 24, and 48 months and analysed for tenofovir diphosphat…
Journal of the American Medical Association
19.03.2024
The number of registered nurses (RNs) dipped in the US during the COVID-19 pandemic, when more than 25% of nurses said they planned to stop practicing by 2027 because of a combination of burnout from understaffing and lack of control over scheduling, among other factors.
BMJ Open
19.03.2024
. Introduction. Young people aged 18–24 years old are a key demographic target for eliminating HIV transmission globally. Pre-exposure prophylaxis (PrEP), a prevention medication, reduces HIV transmission. Despite good uptake by gay and bisexual men who have sex with men, hesitancy to use PrEP has been observed in other groups, such as young people and people from ethnic minority backgrounds. The aim of this study was to explore young people’s perceptions and attitudes to using PrEP. . Design. A qualit…
PLoS One Infectious Diseases
15.03.2024
by Samantha A. Devlin, Amy K. Johnson, Kimberly A. Stanford, Sadia Haider, Jessica P. Ridgway . Automated algorithms for identifying potential pre-exposure prophylaxis (PrEP) candidates are effective among men, yet often fail to detect cisgender women (hereafter referred to as “women”) who would most benefit from PrEP. The emergency department (ED) is an opportune setting for implementing automated identification of PrEP candidates, but there are logistical and practical challenges at the individual, p…
BMJ Open
13.03.2024
. Introduction. Oral pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention method; however, uptake and persistence have been low among southern African women. A dual prevention pill (DPP) that combines PrEP with oral contraception (OC) may increase PrEP use and better meet women’s sexual and reproductive health needs. We will gauge the DPP’s acceptability in two cross-over clinical trials. . Methods and analysis. PC952 (Zimbabwe) and PC953 (South Africa) will compare acceptability, adher…
Clinical Microbiology and Infection
8.03.2024
Four years after the onset of COVID-19 as global public health threat that rapidly achieved pandemic proportions, it is has become commonplace both in layperson and expert circles to refer to it as a watershed. Its global reach, the attributable burden of deaths and morbidity, its enormous socioeconomic consequences, and the fact that SARS-CoV-2 has later joined the common pool of respiratory viruses considered in clinical practice, make COVID-19 special compared to its immediate precedents (e.g., SARS in 2…
American Journal of Tropical Medicine and Hygiene
6.03.2024
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 110 Issue: 3 Pages: 417-420. .
BMJ Open
29.02.2024
…ned from the Institutional Scientific and Ethics Review Committee at the Aga Khan University and the University of Manitoba. . This study will generate evidence on root cultural, structural, socioeconomic and political factors that perpetuate gender inequities and female disadvantage in the paid and unpaid health sectors. It will also identify evidence-based policy options for future safeguarding of the unpaid and paid female health workforce during emergency preparedness, response and recovery periods. .
BMC Infectious Diseases
27.02.2024
…d. The presence of untreated sexually transmitted infections (STIs) significantly increases the chance of acquiring HIV. In Brazil, testing for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) among Pre-Exposure Prophylaxis (PrEP) users is insufficient, and syndromic treatment is a priority in clinical practice. Multi-site testing for CT/NG improves thescreening of asymptomatic cases and ensures timely treatment. Therefore, it is essential for HIV prevention. This study aims t…
Clinical Infectious Diseases
13.02.2024
…ual emergence of SARS-CoV-2 variants introduce limitations in our ability to prevent and treat disease. Project NextGen is a collaboration between the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR), and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, that is leveraging public-private partnerships to address gaps in the nation’s COVID-19 vaccine and therap…
AIDS
2.01.2024
Background: . While recognized as a key HIV prevention strategy, preexposure prophylaxis (PrEP) availability and accessibility are not well documented globally. We aimed to describe PrEP drug registration status and the availability of PrEP services across HIV care sites participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium. Methods: . We used country-level PrEP drug registration status from the AIDS Vaccine Advocacy Coalition and data from IeDEA surveys co…
Journal of Acquired Immune Deficiency Syndromes
2.01.2024
Background: . HIV pre-exposure prophylaxis (PrEP) is a highly effective method to mitigate the HIV epidemic, but uptake of PrEP has been slow and is associated with racial and gender disparities. Oral PrEP requires high levels of adherence to be effective, which may disadvantage certain high-risk groups. The first injectable HIV PrEP, a drug given every two months rather than as a daily pill, was approved by the FDA in December 2021. Setting: . A Family Medicine practice in a single health organization in…
Journal of Acquired Immune Deficiency Syndromes
2.01.2024
No abstract available
Journal of Acquired Immune Deficiency Syndromes
2.01.2024
…isk of HIV acquisition and reduced engagement in HIV care. There is limited understanding of the ways in which IPV exposure and other maladaptive relationship dynamics may influence adherence to antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) for individuals in committed, HIV serodifferent partnerships. Methods . We used binomial generalized linear mixed effect regression models to evaluate the association between IPV exposure and ART/PrEP adherence among members of serodifferent couples…
Emerg Microbes Infect
30.12.2023
Volume 12, Issue 1, December 2023 .
Clinical Infectious Diseases
9.12.2023
Abstract . We used group-based trajectory models to identify four distinct trajectory patterns of adherence to pre-exposure prophylaxis (PrEP) among 20,696 users. Only 44.5% were consistently PrEP adherent, with younger age, being female, or having substance use disorder or depression associated with early discontinuation. Public health efforts are needed to improve PrEP adherence.
Clinical Infectious Diseases
9.12.2023
Abstract . We used group-based trajectory models to identify four distinct trajectory patterns of adherence to pre-exposure prophylaxis (PrEP) among 20,696 users. Only 44.5% were consistently PrEP adherent, with younger age, being female, or having substance use disorder or depression associated with early discontinuation. Public health efforts are needed to improve PrEP adherence.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Eurosurveillance latest updates
29.03.2024
. Background. Pre-exposure prophylaxis (PrEP) effectively prevents HIV, but its association with sexually transmitted infections (STIs) has raised concerns about risk compensation, potentially impacting the expansion of PrEP programmes. . . Aim. We examined the relationship between PrEP and the incidence of chlamydia, gonorrhoea and syphilis. . . Methods. In this prospective cohort study, we compared STI rates before and after PrEP initiation among users in the capital region of Denmark (2019–2022),…
ECDC COVID-19 updates
20.03.2024
This guidance outlines key strategic and operational considerations to inform pandemic preparedness planning round the design and implementation of public health and social measures in community settings in the EU/EEA.
Medscape Infectious Diseases
7.03.2024
AstraZeneca plans to invest 650 million pounds ($826.80 million) in Britain to boost research, development and manufacturing of vaccines, the government announced on. . Reuters Health Information
Medscape Infectious Diseases
1.12.2023
Europe's advances in HIV prevention strategies, including PrEP and long-acting retrovirals, bring hope amidst persistent access challenges and disparities. . Medscape Medical News
Medscape Infectious Diseases
15.09.2023
On the cusp of respiratory virus season, experts offer their guidance to primary care physicians about how to advise patients about vaccines for COVID-19, influenza, and RSV. . Medscape Medical News
ProMED
27.05.2023
Botulism -- Belarus1. Hughes JM, Hatheway CL, Ostroff SM. Botulism. In: Infections of the Central Nervous System. Scheld WM, Whitley RJ, Durack DT, eds., 2nd ed. Philadelphia: Lippincott-Raven, 1997, 615-28.- Mod.LLProMED map:Brest Region, Belarus: ][See Also:2022----Botulism - Ukraine (03): (KK) dried fish promedmail.org/post/20221002.8705918Botulism - Ukraine (02) promedmail.org/post/20220619.8703951Botulism - Kyrgyzstan promedmail.org/post/20220605.8703692Botulism -
Eurosurveillance latest updates
16.03.2023
An individualised blood donor selection policy was implemented in the United Kingdom from summer 2021. We have investigated the impact of this policy by comparing the extent of undeclared use of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) before and after this change. The rate of PrEP usage in syphilis-positive male blood donors has not changed since individualised donor assessment was implemented but provides continuing evidence of undisclosed PrEP use which may be associated with current or p…
Eurosurveillance latest updates
2.02.2023
Eurosurveillance latest updates
19.01.2023
Medscape Infectious Diseases
13.12.2022
"Since the launch of the medRxiv preprint server in 2019, the dissemination of research as preprints has grown rapidly, largely facilitated by the COVID-19 pandemic." . WebMD Health News
Medscape Infectious Diseases
8.12.2022
Preventive cancer screenings have not completely rebounded almost 3 years after the start of the pandemic, new research suggests. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
2.12.2022
This report describes appliances other than ovens used to cook frozen stuffed chicken products.
Eurosurveillance latest updates
24.11.2022
Eurosurveillance latest updates
20.10.2022
Medscape Infectious Diseases
7.10.2022
"When novel public health emergencies arise, extant ones cannot go by the wayside." .
ECDC COVID-19 updates
26.09.2022
This technical report presents an analysis focusing on three issues (testing and surveillance, healthcare sector coordination, and emergency risk communication) during the first phase of the COVID-19 pandemic.
Eurosurveillance latest updates
1.09.2022
ECDC COVID-19 updates
29.08.2022
This document sets out a number of scenarios that are intended to be plausible, internally consistent, and coherent descriptions of possible futures.
Medscape Infectious Diseases
15.06.2022
Educating primary care clinicians about preexposure prophylaxis for HIV could help ease the shortage in clinicians who prescribe the drugs, a study found. .
Medscape Infectious Diseases
24.05.2022
The FDA announced a June advisory committee meeting about COVID vaccines for kids younger than 6. The AMA has updated its billing codes ahead of an expected decision on Moderna's shot in this age group .